$RGNX REGENXBIO Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in REGENXBIO Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in REGENXBIO Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in REGENXBIO Inc. for free.

CIK Number: 0001590877
IRS Number: 471851754
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: RGNX
Company Address: 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE 20850
Phone number: 240-552-8181
Former name: REGENXBIO, Inc., date of change: 2015-01-16
Former name: ReGenX Biosciences, LLC, date of change: 2013-11-01

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Market Capitalization: $465.96M
Prev close: $17.15
Average Daily Volume: 221,868
Days Low: $16.85
Year Low: $7.07
Year High: $24.55

REGENXBIO Inc. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Christmas Patrick J.SVP, General Counsel8,058138,195shares bought: 91,917 / shares sold: -90,486 BUYSep 16 201930 days ago
Mills Kenneth T.President and CEO251,0004,304,650shares bought: 628,530 / shares sold: -382,970 BUYSep 23 201923 days ago

View all REGENXBIO Inc. insiders.

REGENXBIO Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.855,0004,25079,670
Sep 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS39.917,773310,220241,000248.8 K to 241 K (-3.12 %)
Sep 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS39.192,22787,276248,773251 K to 248.8 K (-0.89 %)
Sep 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.855,0004,250251,000246 K to 251 K (+2.03 %)
Sep 16 2019RGNXREGENXBIO Inc.Christmas Patrick J.SVP, General Counse ...Option ExerciseM12.105,00060,50039,931
Sep 16 2019RGNXREGENXBIO Inc.Christmas Patrick J.SVP, General Counse ...SellS42.005,486230,4122,5728.1 K to 2.6 K (-68.08 %)
Sep 16 2019RGNXREGENXBIO Inc.Christmas Patrick J.SVP, General Counse ...BuyM12.105,00060,5008,0583.1 K to 8.1 K (+163.51 %)
Aug 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.8515,00012,75084,670
Aug 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS37.9237614,258246,000246.4 K to 246 K (-0.15 %)
Aug 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS37.5414,624548,985246,376261 K to 246.4 K (-5.60 %)
Aug 21 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.8515,00012,750261,000246 K to 261 K (+6.10 %)
Jul 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOOption ExerciseM0.8515,00012,75099,670
Jul 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS49.972,300114,931246,000248.3 K to 246 K (-0.93 %)
Jul 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOSellS49.4012,700627,380248,300261 K to 248.3 K (-4.87 %)
Jul 23 2019RGNXREGENXBIO Inc.Mills Kenneth T.President and CEOBuyM0.8515,00012,750261,000246 K to 261 K (+6.10 %)

View all REGENXBIO Inc. insider transactions.